Arcoma

Arcoma Net Tangible Assets

The Net Tangible Assets of Arcoma (ARCOMA.ST) as of Oct 26, 2026 is 74.73 M SEK. In the previous year, Net Tangible Assets was 40.85 M SEK — a change of 82.95% (higher).

Net Tangible Assets

74.73 MSEK

YoY

82.95%

Last updated:

Net Tangible Assets of Arcoma is 2025 74.73 M SEK. Net Tangible Assets of Arcoma was 2024 40.85 M SEK. It decreases by 82.95% higher compared to the previous year.

The Arcoma Net Tangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Tangible Assets
Date
Net Tangible Assets
Jan 1, 2018
24.24 M SEK
Jan 1, 2019
23.65 M SEK
Jan 1, 2020
20.21 M SEK
Jan 1, 2021
17.19 M SEK
Jan 1, 2022
21.20 M SEK
Jan 1, 2023
29.26 M SEK
Jan 1, 2024
40.85 M SEK
Jan 1, 2025
74.73 M SEK
The Arcoma Net Tangible Assets history
YEARNet Tangible AssetsYoY
74.73 MSEK+82.95%
40.85 MSEK+39.58%
29.26 MSEK+38.06%
21.20 MSEK+23.34%
17.19 MSEK-14.98%
20.21 MSEK-14.53%
23.65 MSEK-2.43%
24.24 MSEK+12.34%
21.58 MSEK+46.62%
14.71 MSEK-26.01%
19.89 MSEK+107.04%
9.61 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Arcoma Stock analysis

What does Arcoma do? Arcoma AB generates revenue through the sale of its digital radiographic systems, which include complete systems like ceiling suspensions and floor-mounted units, as well as detectors and components such as overhead tube cranes and radiographic tables. The company markets its products under the IMIX brand, through private label distributors, and as original equipment manufacturer (OEM) solutions. Its primary customers are hospitals, clinics, imaging centers, and private practices seeking digital imaging technology with advanced mobile positioning systems. The Precision and Elite mobile imaging table series are key product offerings within its portfolio. The company's business model relies on direct sales of IMIX-branded systems to healthcare facilities, while also supplying components to private label distributors and OEM partners. These channels allow Arcoma to reach a broad range of healthcare providers across different segments. The firm's product range targets facilities requiring flexible, mobile imaging solutions for diagnostic procedures. Arcoma AB's revenue streams are derived from the sale of complete radiographic systems, system components, and mobile imaging tables, all designed for healthcare environments. The IMIX brand represents the company's direct-to-customer offering, while private label and OEM arrangements provide additional distribution pathways. The Precision and Elite series specifically cater to the needs of medical practices requiring mobile diagnostic equipment. Arcoma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Arcoma stock

Net Tangible Assets of Arcoma is 74.73 M SEK in 2025.

Net Tangible Assets of Arcoma changed from 40.85 M SEK to 74.73 M SEK, representing a 82.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Tangible Assets Arcoma since 2006 – with annual values, charts, and detailed analysis.

Net tangible assets equal total assets minus intangible assets, goodwill, and liabilities. They represent the physical asset backing of a company.

Net Tangible Assets's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Tangible Assets's Arcoma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Arcoma

All Key Metrics — Arcoma